Lung nodule program provides benefits to patients ineligible for lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainAdopting a lung nodule program (LNP) may increase the detection of early lung cancer for patients who are not

Updated on: December 30,2023

Lung nodule program provides benefits to patients ineligible for lung cancer screening

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainAdopting a lung nodule program (LNP) may increase the detection of early lung cancer for patients who are not

Updated on:December 30,2023

Blood-based biomarker may redefine future treatment for advanced melanoma

byElsevierCirculating tumor DNA (ctDNA) correlates with radiology disease assessment and patient outcome. For patient A, biomarkers in their blood decreased over time and the radiology showed th

Updated on: January 05,2024

Blood-based biomarker may redefine future treatment for advanced melanoma

byElsevierCirculating tumor DNA (ctDNA) correlates with radiology disease assessment and patient outcome. For patient A, biomarkers in their blood decreased over time and the radiology showed th

Updated on:January 05,2024

Graphene Brain Chip Pioneers Cancer Cell Localization

Updated on: November 07,2024

Graphene Brain Chip Pioneers Cancer Cell Localization

Updated on:November 07,2024

Fat fuels aggressive brain cancers

byCardiff UniversityGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Fat is powering tumour growth in brain cancer, finds

Updated on: December 18,2023

Fat fuels aggressive brain cancers

byCardiff UniversityGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Fat is powering tumour growth in brain cancer, finds

Updated on:December 18,2023

Liquid biopsy predicts immunotherapy response and toxicity in patients with advanced lung cancer

byJohns Hopkins University School of MedicineLiquid biopsy to study genetic material shed into bloodstream helps predict response to immunotherapy. Credit: Valsamo "Elsa" Anagnostou us

Updated on: January 25,2024

Liquid biopsy predicts immunotherapy response and toxicity in patients with advanced lung cancer

byJohns Hopkins University School of MedicineLiquid biopsy to study genetic material shed into bloodstream helps predict response to immunotherapy. Credit: Valsamo "Elsa" Anagnostou us

Updated on:January 25,2024

Preoperative immunotherapy for mesothelioma shows favorable outcomes

by Dipali Pathak,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainIn a study published recently in the journalClinical Cancer Research, researchers at Baylor College of Medicine

Updated on: January 04,2024

Preoperative immunotherapy for mesothelioma shows favorable outcomes

by Dipali Pathak,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainIn a study published recently in the journalClinical Cancer Research, researchers at Baylor College of Medicine

Updated on:January 04,2024

Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Updated on: December 20,2023

Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Updated on:December 20,2023

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-

Updated on: January 04,2024

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-

Updated on:January 04,2024

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit

Updated on: January 05,2024

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit

Updated on:January 05,2024

Key discovery advances fight to reduce breast cancer recurrence

byDuke-NUS Medical SchoolLoss of Gα13 in ER+ breast cancer cells leads to increased cell growth and tumour development, suggesting that Gα13 may suppress tumours in this subtype of cancer. Credi

Updated on: September 06,2024

Key discovery advances fight to reduce breast cancer recurrence

byDuke-NUS Medical SchoolLoss of Gα13 in ER+ breast cancer cells leads to increased cell growth and tumour development, suggesting that Gα13 may suppress tumours in this subtype of cancer. Credi

Updated on:September 06,2024

Racial disparities in lung cancer start with research

by Melba NewsomeCredit: Pixabay/CC0 Public DomainDuring a routine visit to the Good Samaritan Clinic in Morganton, North Carolina, in 2018, Herbert Buff casually mentioned that he sometimes had troubl

Updated on: December 22,2023

Racial disparities in lung cancer start with research

by Melba NewsomeCredit: Pixabay/CC0 Public DomainDuring a routine visit to the Good Samaritan Clinic in Morganton, North Carolina, in 2018, Herbert Buff casually mentioned that he sometimes had troubl

Updated on:December 22,2023

Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainResearchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in

Updated on: December 20,2023

Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainResearchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in

Updated on:December 20,2023